Tracking diabetes cases in children and teenagers in Reunion Island
Evaluation of the Incidence of Diabetes Revealed at Pediatric Age in Reunion
This study is tracking all cases of diabetes in kids and teens under 18 in Reunion Island for five years to see how common it is and to learn more about the types, especially type 2 diabetes related to obesity.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | N/A to 18 Years |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de la Réunion Academic / other |
| Locations | 4 sites (Saint-Benoît and 3 other locations) |
| Trial ID | NCT04174508 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect comprehensive data on all cases of diabetes diagnosed in children and adolescents under 18 years of age in Reunion Island over a five-year period. It focuses on understanding the incidence and types of diabetes, particularly the emerging cases of type 2 diabetes linked to obesity, in a region where precise data has previously been lacking. The study will involve prospective data collection from various hospitals in the region to ensure a thorough understanding of pediatric diabetes trends.
Who should consider this trial
Good fit: Ideal candidates for this study are children and adolescents under 18 years old who are diagnosed with diabetes while residing in Reunion Island.
Not a fit: Patients who do not reside in Reunion Island or who are diagnosed with diabetes after the age of 18 will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the rising incidence of diabetes in children, potentially guiding prevention and treatment strategies.
How similar studies have performed: While there is limited data on similar studies specifically in Reunion Island, the increasing global focus on pediatric diabetes suggests that understanding local trends could be beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * child or adolescent residing in the territory of the reunion island * with a diagnosis that revealed diabetes according to criteria defined by WHO (World Health Organization) before 18 years of age * Parents who signed the participation consent Exclusion Criteria: * Patient not residing in the usual way in Reunion island
Where this trial is running
Saint-Benoît and 3 other locations
- Groupe Hospitalier Est Réunion — Saint-Benoît, France (Recruiting)
- Centre Hospitalier Universitaire Réunion — Saint-Denis, France (Recruiting)
- Centre Hospitalier Ouest Réunion — Saint-Paul, France (Recruiting)
- Centre Hospitalier Universitaire Réunion — Saint-Pierre, France (Recruiting)
Study contacts
- Principal investigator: Laure HOUDON, MD — Centre Hospitalier Universitaire de La REUNION
- Study coordinator: Lucie AUZANNEAU
- Email: lucie.auzanneau@chu-reunion.fr
- Phone: (0)262359949
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.